SCHEMBL48694

SCHEMBL48694

OC1CCNCC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17786304 1.00
SCHEMBL22620863 1.00
SCHEMBL2621296 1.00
SCHEMBL6103993 1.00
SCHEMBL3248723 1.00
SCHEMBL14389126 1.00
SCHEMBL6104004 1.00
Hydrochloric Acid SCHEMBL17801619 0.97
Hydrochloric Acid SCHEMBL6500584 0.97
Hydrochloric Acid SCHEMBL17801618 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117881397-A Heterocyclic compounds and methods of use 安进公司 2024-04-12 CN claimed
CN-110496163-A The preparation method of citrous bud or flower or branch or leaf or fruit active component or ingredient and its application in medicine preparation UNIV JIANGXI TRADITIONAL CHINESE MEDICINE 2019-11-26 CN claimed
CN-110064002-A Flores aurantii and branches and leaves active component or ingredient improve sleep or antidepression in preparation or improve the application in failure of memory drug or food 江西中医药大学 2019-07-30 CN claimed
EP-3059239-B1 SULFUR-CONTAINING BICYCLIC COMPOUND ASTELLAS PHARMA INC (JP) 2018-06-27 EP claimed
EP-3334733-A1 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE Pfizer Inc (US) 2018-06-20 EP claimed
WO-2017025868-A1 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE PFIZER INC. (US) 2017-02-16 WO claimed
CN-105517550-A Characterization of rice PHYTOQUEST LTD 2016-04-20 CN claimed
EP-0765865-B1 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION SEIKAGAKU KOGYO CO LTD (JP) 2001-12-12 EP claimed
US-5763438-A ANTIVIRAL AGENTS SEIKAGAKU CORPORATION (JP) 1998-06-09 US claimed
EP-0765865-A1 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION SEIKAGAKU CORPORATION (JP) 1997-04-02 EP claimed
US-20260083723-A1 THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS TORAY INDUSTRIES, INC. (JP) 2026-03-26 US disclosed
US-12570639-B2 Tetrahydroquinoline derivative and medicinal use thereof TORAY INDUSTRIES, INC. (JP) 2026-03-10 US disclosed
WO-2025235797-A1 POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS COMPRISING ANTIBODIES FOR THE DEGRADATION OF TARGETED PROTEINS AVILAR THERAPEUTICS, INC. (US) 2025-11-13 WO disclosed
US-12441704-B2 Compounds active towards nuclear receptors NUEVOLUTION A/S (DK) 2025-10-14 US disclosed
US-20250289801-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION 2025-09-18 US disclosed
US-5763438-A ANTIVIRAL AGENTS SEIKAGAKU CORPORATION (JP) 1998-06-09 US disclosed
EP-0765865-A1 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION SEIKAGAKU CORPORATION (JP) 1997-04-02 EP disclosed
US-5264204-A Hydrophilic free radicals for magnetic resonance imaging MALLINCKRODT MEDICAL, INC. (US) 1993-11-23 US disclosed
WO-1993022662-A1 HYDROPHILIC FREE RADICALS FOR MAGNETIC RESONANCE IMAGING MALLINCKRODT MEDICAL, INC. (US) 1993-11-11 WO disclosed
US-3998827-A HYPOTENSIVE AGENTS THE UPJOHN COMPANY (US) 1976-12-21 US disclosed